Telmital-CT Tablet
Marketer
Talent India
Salt Composition
Telmisartan (40mg) + Chlorthalidone (12.5mg)
Overview Telmital-CT Tablet
Telmital-CT tablets combine two medications to effectively manage hypertension. This dual action reduces the long-term risk of stroke and heart attack. The tablets may be taken with or without food, with dosage adjusted based on individual response and health status. Consistent daily timing is recommended. Continue taking the medication as directed by your physician; discontinuation increases stroke and heart attack risk. The formulation includes a diuretic, increasing urination; therefore, avoid taking it within four hours of bedtime. Regular use is crucial for optimal benefit, even in the absence of noticeable symptoms (as hypertension is often asymptomatic). Common side effects include dizziness; less frequent occurrences may involve nausea, diarrhea, headache, and altered lipid profiles. Increased urination is an intended effect of the chlorthalidone component, aiding blood pressure control, not a side effect. While rare, other side effects are possible. Consult the patient information leaflet and inform your doctor of any persistent or bothersome side effects; dosage adjustment or alternative medication may be considered. This medication is unsuitable during pregnancy and requires physician consultation if you have kidney or liver disease, cardiac issues, or diabetes. Alcohol consumption may exacerbate blood pressure reduction and side effects.
Uses of Telmital-CT Tablet
Elevated arterial blood pressure
Major Benefits of Telmital-CT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Telmital-CT Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Telmital-CT Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Telmital-CT Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmital-CT Tablets can be administered with or without food, although consistent timing is recommended.
How Telmital-CT Tablet works:
Telmital-CT tablets contain a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmital-CT Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telmital-CT tablets during pregnancy is strongly discouraged due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Using Telmital-CT tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Telmital-CT Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmital-CT Tablets, potentially requiring dosage modification under medical supervision. Its use is generally discouraged in such individuals.
LiverCAUTION
Patients with hepatic impairment should use Telmital-CT Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Telmital-CT Tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Telmital-CT Tablet :
Should you forget a Telmital-CT Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Telmital-CT Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |






